Cold Spring Harbor, NY — Cold Spring Harbor Laboratory (CSHL) today announced the appointment of life science business leader Andrew Whiteley as the new Vice President of Business Development and Technology Transfer.
Whiteley, who has served as Executive in Residence at CSHL since November 2015, now leads a dedicated team that supports scientists in commercialization activities including licensing, company start-ups, corporate partnerships and academic-industry collaborations. His previous experience includes: Director of Scientific and Medical Programs at Lustgarten Foundation; Chief Operating Officer and Vice President Business Development at Enzo Biochem; Vice President for Bioinformatics and Sequencing for Amersham Life Sciences; and CEO of three early stage biotech companies.
“As a global pioneer in biological research, CSHL is focused on bringing its discoveries to society through partners that provide expertise and resources to commercialize across industries ranging from biotech, pharmaceuticals, energy, agriculture and healthcare,” said Whiteley. “I’m proud to be leading an in-house Business Development and Technology Transfer team well-equipped in licensing and optioning, sponsored research, [and] intellectual property management.”
Whiteley succeeds Teri Willey, who served as Vice President of the department from 2013 until March 12, 2018, leaving CSHL to launch a new philanthropic venture fund for an affiliate of Indiana University. Willey was the first person to hold this prestigious position, and was responsible for the success of several CSHL spinoffs.
Written by: Sara Roncero-Menendez, Media Strategist | firstname.lastname@example.org | 516-367-8455